Hyperpigmentation Disorder Treatment Market Report 2026

The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $6.12 billion in 2025 to $6.65 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of melasma and PIH, rising aesthetic awareness, growth of dermatology clinics, widespread use of topical depigmenting agents, increasing sun exposure.

The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing demand for laser and energy-based devices, expansion of personalized skincare treatments, rising disposable income, increased adoption of combination therapies, growing influence of aesthetic medicine. Major trends in the forecast period include growing demand for non-invasive aesthetic treatments, rising preference for combination therapy approaches, increased use of preventive and maintenance skincare regimens, expansion of medical-grade cosmeceuticals, higher adoption of clinic-based advanced procedures.

The rising cosmetic concerns are expected to drive the growth of the hyperpigmentation disorder treatment market going forward. Cosmetic concerns refer to considerations related to the appearance, beauty, or aesthetics of one's physical features. Increasing awareness of these concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. For example, in March 2025, according to Yellow Bus ABA, a US-based therapy group, the global plastic surgery sector in 2023 recorded around 34.9 million aesthetic procedures worldwide, reflecting a 3.4% increase compared to 2022. Thus, growing cosmetic concerns are supporting the expansion of the hyperpigmentation disorder treatment market.

Major companies in the hyperpigmentation disorder treatment market are focusing on developing glycolic acid solutions to strengthen their market position and gain a competitive edge. Glycolic acid solutions are skincare formulations containing glycolic acid, an alpha hydroxy acid (AHA) recognized for its exfoliating properties, which help enhance skin texture, brightness, and overall appearance by promoting cell turnover. For instance, in February 2024, L'Oréal SA, a France-based personal care company, introduced the Glycolic Bright Dark Circle Eye Serum, designed to address dark circles and dullness around the eyes. This innovative serum contains glycolic acid to promote exfoliation, brighter skin, and improved texture, while also likely including hydrating ingredients to nourish the delicate eye area.

In July 2023, Reveal Lasers LLC, a US-based manufacturer of aesthetic laser and RF devices, merged with NEOconcepts LLC. Through this merger, Reveal Lasers acquired the AgeJET Advanced Plasma Skin Therapy Device, allowing expansion into a new treatment segment and enhancing the device’s presence in the US market. NEOconcepts LLC is a US-based provider of aesthetic treatment products and devices.

Major companies operating in the hyperpigmentation disorder treatment market are Vivier Pharma, Obagi Cosmeceuticals LLC, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.

North America was the largest region in the hyperpigmentation disorders treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the hyperpigmentation disorder treatment market by increasing costs for imported laser systems, aesthetic devices, and specialty skincare ingredients, affecting pricing and clinic investments. These effects are more evident in regions dependent on imported aesthetic technologies, particularly Asia-Pacific and emerging markets. However, tariffs are also encouraging local manufacturing of cosmeceuticals, regional device assembly, and innovation in cost-effective treatment solutions, supporting long-term market sustainability.

The hyperpigmentation disorder treatment market research report is one of a series of new reports that provides hyperpigmentation disorder treatment market statistics, including hyperpigmentation disorder treatment industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment market share, detailed hyperpigmentation disorder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment industry. This hyperpigmentation disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hyperpigmentation disorder treatment encompasses various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing active ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.

The treatment options in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other approaches. Cosmeceuticals are cosmetic products with active ingredients that may provide therapeutic benefits for the skin. They are employed to manage conditions such as melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications, and are used by various end-users including hospitals, aesthetic clinics, dermatology centers, and other healthcare facilities.

The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.